The biotech company Therapeutic Solutions International Inc (OTCMKTS:TSOI) has been in the news this week after it made a major announcement on Wednesday and yesterday, its stock was on the move. As investors piled on to the Therapeutic Solutions International stock, it ended the day with gains of as much as 25%.
In this situation, it might be important for investors to perhaps take a look at the announcement made by Therapeutic Solutions International. On August 18, the company announced the data and in addition to that, the filing of a patent with regards to the mechanism of its universal donor stem cell named JadiCell.
In the study, Therapeutic Solutions International used advanced lung inflammation from animal models and tried to use it for the purposes of replication of inflammation caused by the Delta variant of the COVID 19 virus. In doing so, it was able to judge the importance of CD73 with regards to the expression of T Cells.
The information released by the company was important considering the fact that the Delta variant is currently wreaking havoc in many parts of the world. It is now going to be interesting to see if the Therapeutic Solutions International stock can manage to add to its gains today and end the week strongly.